Neuropeptide Y (3-36) (human, rat)
Not For Human Use, Lab Use Only.
Cat.#: 314408
Special Price 430.10 USD
-
Product Name
Neuropeptide Y (3-36) (human, rat)
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
SKPDNPGEDAPAEDMARYYSALRHYINLITRQRY
-
Sequence
H-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2
-
Length (aa)
34
-
Peptide Purity (HPLC)
96.5%
-
Molecular Formula
C175H269N53O54S
-
Molecular Weight
4011.45
-
Source
Synthetic
-
Form
Powder
-
Description
Neuropeptide Y (3-36) (NPY 3-36) is an endogenous truncated form of NPY 1-36 that lacks the amino-terminal dipeptide Tyr-Pro. It was isolated from porcine brain and accounts for approximately 35% of NPY-like immunoreactivity in brain extracts, indicating that it is generated under physiological conditions, likely through proteolytic cleavage of the full-length peptide. Structural characterization by amino-acid sequencing and mass spectrometry confirmed that NPY 3-36 comprises residues 3-36 of NPY with an amidated carboxy-terminus.
Radioligand binding studies show that NPY 3-36 binds with high affinity to Y2-like receptors, comparable to that of NPY 1-36, but has approximately 1000-fold lower affinity for Y1-like receptors. Thus, amino-terminal cleavage of NPY 1-36 converts an unselective Y1/Y2 receptor ligand into a highly Y2-selective ligand. NPY 3-36 represents the first endogenous NPY fragment demonstrated to exhibit Y2 receptor selectivity, and this posttranslational processing may serve as a means of directing NPY actions to distinct receptor subtypes.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
-
References
- Grandt D, Schimiczek M, Rascher W, Feth F, Shively J, Lee TD, Davis MT, Reeve JR Jr, Michel MC. Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors. Regul Pept. 1996 Nov 14;67(1):33-7. doi: 10.1016/s0167-0115(96)00104-8. PMID: 8952003.
-
About TFA salt
Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.
Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.
Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.
- Molar Concentration Calculator
- Dilution Calculator
- Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"